HomeNewsTrendsHealth34 cases of Covid's JN.1 variant detected in Karnataka

34 cases of Covid's JN.1 variant detected in Karnataka

Out of 34 JN.1 cases in State - 20 are from Bengaluru city, while four from Mysuru, three from Mandya, one each from Ramanagara, Bengaluru Rural, Kodagu and Chamarajanagara, and three deaths.

December 25, 2023 / 20:35 IST
Story continues below Advertisement
Representative image
Representative image

The Karnataka Department of Health & Family Welfare Services on Monday said 34 cases of COVID-19's variant JN.1 have been detected in the state so far, which include three deaths.

Earlier in the day, Health Minister Dinesh Gundu Rao had said about 35 cases of JN.1 have been detected in Karnataka so far, but had maintained that the information is subjected to details shared by the department, later. Out of these 34 cases of JN.1 detected in Karnataka, 20 are from Bengaluru city alone.

Story continues below Advertisement

"Samples of Covid-19 positive cases were tested for the newly reported Omicron variant of Covid-19, i.e., JN.1 at National Institute of Virology (NIV), Pune and National Centre for Biological Sciences (NCBS), Bengaluru. Genome sequencing results of 60 samples are available as on date, out of 192 samples submitted....Total 34 cases have been detected as JN.1 variant," the department said in a release.

It said, results of the remaining positive cases may be available by Wednesday.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show